Red tape cuts are front and centre ahead of key pharma vote in Brussels

EU PERSPECTIVES - Less bureaucratic paperwork and protection on a par with that of energy and defence is what key pharma figures want from the Critical Medicines Act (CMA). The legislation, awaiting a 2 December plenary vote, is to secure Europe's medicine supply by reinforcing EU manufacturing and cutting red tape. Read more

MEP Tomislav Sokol (EPP/HRV), rapporteur for Critical Medicines Act / Photo: EP